98(top 4%)
papers
3,636(top 4%, rank 133.7K)
citations
31(top 3%, rank 110.9K)
h-Index
131
rankings
106(top 4%)
extended papers
4,916(top 4%, rank 133.7K)
extended citations
36(top 3%, rank 92.6K)
extended h-Index
7.6
avg. Impact Factor
Journals Duxin Sun published therein
Journal | Articles | Citations | Impact Factor |
---|---|---|---|
Journal of Medicinal Chemistry | 17 | 668 | 8.3 |
Molecular Pharmaceutics | 9 | 184 | 5.6 |
AAPS Journal | 7 | 148 | 3.7 |
International Journal of Pharmaceutics | 3 | 83 | 6.5 |
Acta Pharmaceutica Sinica B | 3 | 4 | 15.5 |
ACS Applied Materials & Interfaces | 3 | 35 | 9.5 |
Cancer Letters | 3 | 89 | 9.9 |
Biomaterials | 2 | 37 | 15.6 |
Scientific Reports | 2 | 32 | 4.9 |
European Journal of Pharmaceutical Sciences | 2 | 40 | 5.1 |
Cancer Cell | 2 | 361 | 24.3 |
Science Translational Medicine | 2 | 29 | 17.5 |
Clinical Pharmacology: Advances and Applications | 2 | 5 | 1.5 |
PLoS ONE | 1 | 50 | 3.7 |
Journal of Biological Chemistry | 1 | 6 | 5.4 |
Journal of Controlled Release | 1 | 58 | 11.7 |
Cancer Research | 1 | 110 | 10.1 |
European Journal of Pharmaceutics and Biopharmaceutics | 1 | 18 | 5.7 |
Frontiers in Oncology | 1 | 19 | 5.3 |
European Journal of Medicinal Chemistry | 1 | 1 | 6.8 |
Journals cited Duxin Sun
Journals Duxin Sun referenced
Journal | References | Impact Factor |
---|---|---|
Cancer Research | 124 | 10.1 |
Journal of Medicinal Chemistry | 123 | 8.3 |
Proceedings of the National Academy of Sciences of the United States of America | 117 | 11.5 |
Molecular Pharmaceutics | 99 | 5.6 |
Nature | 96 | 50.4 |
Journal of Pharmaceutical Sciences | 80 | 3.9 |
Clinical Cancer Research | 77 | 12.9 |
Journal of Controlled Release | 72 | 11.7 |
Pharmaceutical Research | 66 | 4.5 |
Journal of Biological Chemistry | 65 | 5.4 |
Journal of Clinical Oncology | 62 | 2.2 |
Biomaterials | 61 | 15.6 |
Cell | 54 | 56.2 |
PLoS ONE | 54 | 3.7 |
New England Journal of Medicine | 50 | 59.2 |
European Journal of Pharmaceutical Sciences | 50 | 5.1 |
Science | 48 | 33.3 |
Journal of Clinical Investigation | 48 | 15.9 |
Cancer Cell | 46 | 24.3 |
Advanced Drug Delivery Reviews | 43 | 18.5 |